Felipe Couñago PhD (@fcounago) 's Twitter Profile
Felipe Couñago PhD

@fcounago

Rad Onc. National Clinical Director of GenesisCare Spain. San Francisco de Asis, La Milagrosa Hospitals. National Chair of Research. MRIdian Project

ID: 1292576653

linkhttps://www.genesiscare.com/es calendar_today23-03-2013 21:44:20

8,8K Tweet

2,2K Followers

4,4K Following

Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

🇪🇸 Our Spanish multicenter study on SBRT for localized prostate cancer is featured by UroToday.com ! ✅ 251 pts, 12 centers ✅ Low acute toxicity ✅ Real-world data 🔗 urotoday.com/recent-abstrac… 🙏 Thanks @UroToday for highlighting our work! #SBRT #ProstateCancer #RadOnc

🇪🇸 Our Spanish multicenter study on SBRT for localized prostate cancer is featured by <a href="/urotoday/">UroToday.com</a> !

✅ 251 pts, 12 centers
✅ Low acute toxicity
✅ Real-world data

🔗 urotoday.com/recent-abstrac…

🙏 Thanks @UroToday for highlighting our work!

#SBRT #ProstateCancer #RadOnc
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

Just published results from URONCOR 06-24! A randomized trial on ADT duration with salvage RT in prostatecancer recurrence. 📄122 pts in actasurologicas 📆 Update with >200 pts at ESTRO 2026! 🙏 Thanks to patients, families, IRAD, SEOR & all teams! 🔗 bit.ly/uroncor122

Just published results from URONCOR 06-24!
A randomized trial on ADT duration with salvage RT in prostatecancer recurrence.
📄122 pts in <a href="/actasurologicas/">actasurologicas</a>
📆 Update with &gt;200 pts at ESTRO 2026!
🙏 Thanks to patients, families, IRAD, SEOR &amp; all teams!
🔗 bit.ly/uroncor122
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

🚻 In MIBC, BPT ≈ RC in HRQoL at 2y. 🧠 BPT: better cognition, sexual function, body image 😌 RC: better pain & emotional well-being 👉 Shared decisions matter. 📄 redjournal.org/article/S0360-… #BladderCancer #HRQoL #OncoUrology

SRS SBRT Spanish Group (@srs_sbrt_sg) 's Twitter Profile Photo

Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases – A Case-Based Radiosurgery Society Practice Guide and Review - Practical Radiation Oncology practicalradonc.org/article/S1879-…

Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

🎯 20 months, 250 patients 📄 2 papers out, 1 under review 🎓 Fellowship (2023–25) 📢 Symposia & congresses on MR-Linac (2023–24) 🎤 SEOR & ESTRO 2022–24 💙 Onco Solidario: free tx for 💵-limited pancreatic cancer patients 🏥 Visits incl. Ramón Reyes (AECC) We keep going 💪🏻

🎯 20 months, 250 patients
📄 2 papers out, 1 under review
🎓 Fellowship (2023–25)
📢 Symposia &amp; congresses on MR-Linac (2023–24)
🎤 SEOR &amp; ESTRO 2022–24
💙 Onco Solidario: free tx for 💵-limited pancreatic cancer patients
🏥 Visits incl. Ramón Reyes (AECC)

We keep going 💪🏻
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

🎉 Excited to share our work is on the Genes July 2025 cover! 🧬 “Radiogenomics of Stereotactic Radiotherapy” 🔗 doi.org/10.3390/genes1… Proud to highlight the synergy of SBRT & personalized medicine. Damir Vucinic | Matea Lekic

🎉 Excited to share our work is on the Genes July 2025 cover! 🧬
“Radiogenomics of Stereotactic Radiotherapy”
🔗 doi.org/10.3390/genes1…
Proud to highlight the synergy of SBRT &amp; personalized medicine.
Damir Vucinic | Matea Lekic
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

📢 Our article on ADT duration + salvage RT in prostate cancer (URONCOR 06-24 trial) is now online! 🧠 Open access for 50 days: 👉 authors.elsevier.com/c/1lUCL_4oIYIT… #ProstateCancer #RadiationOncology #ClinicalResearch #URONCOR0624

📢 Our article on ADT duration + salvage RT in prostate cancer (URONCOR 06-24 trial) is now online!
🧠 Open access for 50 days:
👉 authors.elsevier.com/c/1lUCL_4oIYIT…

#ProstateCancer #RadiationOncology #ClinicalResearch #URONCOR0624
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

New paper in EJNMMI! 📄 Rechallenge with [¹⁷⁷Lu]Lu-PSMA shows promising efficacy & safety in mCRPC. Thanks to my friend Mo Shelan for inviting me to join this great work! 👉 doi.org/10.1007/s00259… #ProstateCancer #Lu177 #Theranostics #PSMA #NuclearMedicine

New paper in EJNMMI!
📄 Rechallenge with [¹⁷⁷Lu]Lu-PSMA shows promising efficacy &amp; safety in mCRPC.
Thanks to my friend Mo Shelan for inviting me to join this great work!
👉 doi.org/10.1007/s00259…
#ProstateCancer #Lu177 #Theranostics #PSMA #NuclearMedicine
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

🆕 Review in Frontiers in Oncology Reviews 📌 Triplet therapy in mHSPC 💉💊🧬 Critically assessed in a GUARD-led multidisciplinary paper 🙏 Proud co-author! 🔗 frontiersin.org/articles/10.33… #ProstateCancer #mHSPC #TripletTherapy #OncoTwitter 🔬👨‍⚕️👩‍⚕️ @GUARDconsortium

🆕 Review in Frontiers in Oncology Reviews
📌 Triplet therapy in mHSPC 💉💊🧬
Critically assessed in a GUARD-led multidisciplinary paper
🙏 Proud co-author!
🔗 frontiersin.org/articles/10.33…
#ProstateCancer #mHSPC #TripletTherapy #OncoTwitter 🔬👨‍⚕️👩‍⚕️ @GUARDconsortium
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

🎓 ¡Felicidades a Leticia del Campo (FJD) y Claudia Colón (Servet) por su fellowship en MR-Linac con nosotros! 🧲 Aprendieron a manejar todo el workflow en MRIdian, casos clínicos complejos y a participar en investigación clínica. 👏 ¡Gran futuro por delante!

🎓 ¡Felicidades a Leticia del Campo (FJD) y Claudia Colón (Servet) por su fellowship en MR-Linac con nosotros!

🧲 Aprendieron a manejar todo el workflow en MRIdian, casos clínicos complejos y a participar en investigación clínica.

👏 ¡Gran futuro por delante!
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

Ayer en el Encontro de Verán 2025 de @Asomega_Galicia en Monforte. Ciencia , ruralidad y reencuentros con sabor a terra 💚. Orgullo de formar parte de una junta liderada por el gran Julio Ancochea 🙌 Galicia, sempre.🐚 #Asomega #MedicinaRural #Galicia asomega.es/actualidad/not…

Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

📢 Just out! Review on GnRH antagonists in prostate cancer in Arch Esp Urol. ✅ No flare ✅ Fast T suppression ✅ Possible CV benefit But evidence still evolving. 🔗 doi.org/10.56434/j.arc… 🙏 Thanks to all co-authors!

📢 Just out!
Review on GnRH antagonists in prostate cancer in Arch Esp Urol.
✅ No flare
✅ Fast T suppression
✅ Possible CV benefit
But evidence still evolving.

🔗 doi.org/10.56434/j.arc…
🙏 Thanks to all co-authors!
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

🎉👏 ¡Congrats to all co-authors! 🧬📄 “Biomarkers in Localized Prostate Cancer: From Diagnosis to Treatment” now in IJMS 📰 🔗🌐 mdpi.com/1422-0067/26/1… 📥💡 mdpi.com/1422-0067/26/1…

🎉👏 ¡Congrats to all co-authors!
🧬📄 “Biomarkers in Localized Prostate Cancer: From Diagnosis to Treatment” now in IJMS 📰

🔗🌐 mdpi.com/1422-0067/26/1…
📥💡 mdpi.com/1422-0067/26/1…
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

📢 New online! URONCOR 06-24 🧪💡 Phase III on optimal ADT + salvage RT duration after prostatectomy in #ProstateCancer. 🙏 Thanks to co-authors, patients, families & team! 🔗 Free 50 days: authors.elsevier.com/a/1laAL7kDkrrQ…

📢 New online!
URONCOR 06-24 🧪💡
Phase III on optimal ADT + salvage RT duration after prostatectomy in #ProstateCancer.

🙏 Thanks to co-authors, patients, families &amp; team!

🔗 Free 50 days: authors.elsevier.com/a/1laAL7kDkrrQ…
Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile Photo

Biomarkers in Localized Prostate Cancer: From Diagnosis to Treatment mdpi.com/1422-0067/26/1… This review explores advances beyond prostate-specific antigen (PSA) in the detection and management of localized #ProstateCancer , focusing on emerging urinary biomarkers (PCA3,

Biomarkers in Localized Prostate Cancer: From Diagnosis to Treatment

mdpi.com/1422-0067/26/1…

This review explores advances beyond prostate-specific antigen (PSA) in the detection and management of localized #ProstateCancer , focusing on emerging urinary biomarkers (PCA3,
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

📢 New in Biomedicines 🎓 🧲 ADC (mpMRI) + 📊 PSA @ 6m after RT+ADT → better 🎯 risk stratification in #ProstateCancer 🔗 doi.org/10.3390/biomed… 👏 Congrats to all authors!

📢 New in Biomedicines 🎓
🧲 ADC (mpMRI) + 📊 PSA @ 6m after RT+ADT → better 🎯 risk stratification in #ProstateCancer
🔗 doi.org/10.3390/biomed…
👏 Congrats to all authors!
Felipe Couñago PhD (@fcounago) 's Twitter Profile Photo

👏 Congrats to the authors! 🧠 New nomogram predicts depression in #BreastCancer (AUC 0.85 ✅). Key: pain 💢, activity 🏃‍♀️, family support 👨‍👩‍👧, income 💰, tumor grade 🧬. ⚠️ Needs validation, but a step forward. #Oncology #MentalHealth DOI: dx.doi.org/10.5306/wjco.v…

👏 Congrats to the authors!
🧠 New nomogram predicts depression in #BreastCancer (AUC 0.85 ✅).
Key: pain 💢, activity 🏃‍♀️, family support 👨‍👩‍👧, income 💰, tumor grade 🧬.

⚠️ Needs validation, but a step forward.
#Oncology #MentalHealth

DOI: dx.doi.org/10.5306/wjco.v…